Results 131 to 140 of about 5,022,316 (352)

Aggressive prostate cancer is associated with pericyte dysfunction

Molecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero, Ane Martinez‐Larrinaga, Joaquim Grego‐Bessa, Saioa Garcia‐Longarte, Hielke van Splunder, Ianire Astobiza, Amaia Ercilla, Laura Bozal‐Basterra, Isabel Mendizabal, Pilar Villacampa, Arkaitz Carracedo, Mariona Graupera   +11 more
wiley   +1 more source

Genetic molecular markers to accelerate genetic gains in crops

BioTechniques, 2020
Rajaguru Bohar, Annapurna Chitkineni, Rajeev K Varshney   +2 more
doaj   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Status of the noble crayfish Astacus astacus (L.) in Germany : monitoring protocol and the use of RAPD markers to assess the genetic structure of populations [PDF]

, 2000
Ralf Schulz
openalex   +1 more source

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

Genetic Marker [PDF]

, 2019
openaire   +3 more sources

Conservation strategies for endemic Dendrocalamus manipureanus: A study on genetic diversity and population structure based on molecular and phytochemical markers

, 2022
Thoungamba Amom, Leimapokpam Tikendra, Angamba Meetei Potshangbam, Nongthombam Bidyananda, Rajkumari Sanayaima Devi, Abhijit Dey, Manas Ranjan Sahoo, Wagner A. Vendrame, Imlitoshi Jamir, Potshangbam Nongdam   +9 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Antiviral Intervention of COVID-19: Linkage of Disease Severity with Genetic Markers FGB (rs1800790), NOS3 (rs2070744) and TMPRSS2 (rs12329760) [PDF]

М.О. Соколенко, Larysa Sydorchuk, Аліна Соколенко, Ruslan Sydorchuk, Iryna Kamyshna, Andriy Sydorchuk, Ludmila Sokolenko, Oleksandr Sokolenko, Valentyn Oksenych, Oleksandr Kamyshnyi   +9 more
openalex   +1 more source

Genetic Markers in Triple‐Negative Breast Cancer

Clinical Breast Cancer, 2018
Z. Sporikova, V. Koudelakova, R. Trojanec, M. Hajdůch   +3 more
semanticscholar   +1 more source